8-K
Current Report
Beam Therapeutics Inc. Filed Acc 0001193125-23-258963
Exit or restructuring costs · Regulation FD disclosure · Other events
- Item 2.05 Costs associated with exit or disposal activities
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d517250d8k.htm…